E. Seyrek

418 total citations
22 papers, 263 citations indexed

About

E. Seyrek is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, E. Seyrek has authored 22 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in E. Seyrek's work include Hematopoietic Stem Cell Transplantation (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Neutropenia and Cancer Infections (3 papers). E. Seyrek is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Neutropenia and Cancer Infections (3 papers). E. Seyrek collaborates with scholars based in Türkiye and United States. E. Seyrek's co-authors include İlhan Tuncer, Berksoy Şahin, Merih Soylu, Gülfiliz Gönlüşen, Melek Ergin, Sibel Hakverdi, Şeyda Erdoğan, Arzu Kanık, Refik Burgut and Sinan Yavuz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Haematology.

In The Last Decade

E. Seyrek

22 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Seyrek Türkiye 10 79 72 68 53 47 22 263
Coralie Derrieux France 9 80 1.0× 128 1.8× 60 0.9× 36 0.7× 34 0.7× 16 297
Florence Burtin France 8 116 1.5× 37 0.5× 82 1.2× 75 1.4× 45 1.0× 17 307
Sei Muraoka Japan 9 57 0.7× 28 0.4× 57 0.8× 34 0.6× 73 1.6× 25 291
Anna Olewicz‐Gawlik Poland 11 40 0.5× 108 1.5× 35 0.5× 36 0.7× 56 1.2× 31 338
A. Balanescu Romania 10 31 0.4× 85 1.2× 57 0.8× 33 0.6× 68 1.4× 47 340
L. Burke United States 8 44 0.6× 179 2.5× 80 1.2× 117 2.2× 67 1.4× 11 374
Shoko Nakayama Japan 9 91 1.2× 80 1.1× 39 0.6× 26 0.5× 34 0.7× 42 267
E. Lévy France 8 124 1.6× 32 0.4× 31 0.5× 71 1.3× 41 0.9× 32 279
Yajing Huang China 9 77 1.0× 26 0.4× 28 0.4× 79 1.5× 38 0.8× 31 298
Arun K. Singavi United States 6 242 3.1× 76 1.1× 40 0.6× 44 0.8× 26 0.6× 14 350

Countries citing papers authored by E. Seyrek

Since Specialization
Citations

This map shows the geographic impact of E. Seyrek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Seyrek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Seyrek more than expected).

Fields of papers citing papers by E. Seyrek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Seyrek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Seyrek. The network helps show where E. Seyrek may publish in the future.

Co-authorship network of co-authors of E. Seyrek

This figure shows the co-authorship network connecting the top 25 collaborators of E. Seyrek. A scholar is included among the top collaborators of E. Seyrek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Seyrek. E. Seyrek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uğurluer, Gamze, Sinan Yavuz, E. Seyrek, et al.. (2016). Correlation between 18F-FDG Positron-Emission Tomography 18F-FDG Uptake Levels at Diagnosis and Histopathologic and Immunohistochemical Factors in Patients with Breast Cancer. SHILAP Revista de lepidopterología. 12(3). 112–118. 10 indexed citations
2.
Mutlu, Hasan, Abdullah Büyükçelik, Mustafa Kibar, et al.. (2013). Does Sunlight Exposure Improve Survival in Patients with Non-small Cell Lung Cancer?. Asian Pacific Journal of Cancer Prevention. 14(11). 6301–6304. 3 indexed citations
3.
Mutlu, Hasan, Abdullah Büyükçelik, Abdülsamet Erden, et al.. (2013). Staging with PET-CT in Patients with Locally Advanced Non Small Cell Lung Cancer is Superior to Conventional Staging Methods in Terms of Survival. Asian Pacific Journal of Cancer Prevention. 14(6). 3743–3746. 12 indexed citations
4.
Mutlu, Hasan, et al.. (2013). Sunlight may increase the FDG uptake value in primary tumors of patients with non-small cell lung cancer. Oncology Letters. 5(3). 773–776. 2 indexed citations
5.
Özdoğan, Mustafa, Serdar Turhal, Devrim Çabuk, et al.. (2012). Frequency of comorbid illnesses in cancer patients in Turkey.. PubMed. 16(3). 557–60. 1 indexed citations
6.
Polat, Ayşe, et al.. (2008). The Influence of HER2 Genotypes as Molecular Markers on Breast Cancer Outcome. DNA and Cell Biology. 27(10). 575–579. 10 indexed citations
7.
Çolak, Tahsin, Tamer Akça, Musa Dirlik, et al.. (2005). Signet Ring Cell Carcinoma of the Breast as a Source of Pelvic Floor Metastatic Mass. A Case Report. Acta chirurgica Belgica. 105(2). 224–226. 5 indexed citations
8.
Polat, Gürbüz, et al.. (2005). The role of fibronectin and nitric oxide (NO) in gastrointestinal cancers.. PubMed. 52(61). 119–22. 2 indexed citations
9.
Seyrek, E., et al.. (2004). Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in Hodgkin's and non-Hodgkin's lymphoma. International Journal of Clinical Practice. 58(2). 139–143. 27 indexed citations
10.
Ergin, Melek, et al.. (2004). Cyclooxygenase-2 (Cox-2) Expression in Lymphomas. Leukemia & lymphoma. 45(7). 1395–1399. 36 indexed citations
11.
Demirer, Taner, Meltem Aylı, Yavuz Selim Genç, et al.. (2003). High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Bone Marrow Transplantation. 31(9). 755–761. 5 indexed citations
12.
Tiftik, Naci, Ahmet Kıykım, Engin Altıntaşž, et al.. (2003). Therapeutic plasma exchange for multidrug intoxication: A case report. Journal of Clinical Apheresis. 18(3). 132–133. 6 indexed citations
13.
Demirer, Taner, Meltem Aylı, Rauf Haznedar, et al.. (2002). Influence of post‐transplant recombinant human granulocyte colony‐stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation. British Journal of Haematology. 118(4). 1104–1111. 18 indexed citations
14.
Demirer, Taner, Osman İlhan, Meltem Aylı, et al.. (2002). A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters. Bone Marrow Transplantation. 29(11). 893–897. 9 indexed citations
15.
Seyrek, E., et al.. (1997). Refractory Breast Cancer: A Comparison of Two Different Chemotherapy Regimens. Journal of Chemotherapy. 9(6). 442–445. 12 indexed citations
17.
Yüreğir, Guneş T., et al.. (1995). Intracellular Glutathione Content in Leukemias. Oncology. 52(2). 112–115. 6 indexed citations
18.
Soylu, Levent, Cengiz Özcan, Fikret Çetik, et al.. (1994). Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck. American Journal of Otolaryngology. 15(4). 281–285. 6 indexed citations
19.
Ergün, Yusuf, et al.. (1993). IS THERE ANY RELATIONSHIP BETWEEN PICA AND LIVER FAILURE ?. International Journal of Clinical Practice. 47(3). 147–149. 1 indexed citations
20.
Şahin, Berksoy, et al.. (1993). Sweet's syndrome associated with G‐CSF. British Journal of Haematology. 85(1). 191–192. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026